Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 10, 2022

Total Value ($000): $222,441 (100.0% shares, 0.0% debt)

Holdings (19)

— AMRYT PHARMA PLC - SPNR ADR 19.4%

Value ($000) $43,096 Shares 6,227,733 Est. Cost $12.42 Unrealized —

QDEL QUIDELORTHO CORP 16.1%

Value ($000) $35,857 Shares 501,633 Est. Cost $92.45 Unrealized -3.2%

— CTI BIOPHARMA CORP 14.8%

Value ($000) $32,996 Shares 5,669,388 Est. Cost $3.66 Unrealized —

XERS XERIS BIOPHARMA HOLDINGS INC 9.1%

Value ($000) $20,168 Shares 12,928,168 Est. Cost $2.15 Unrealized -22.9%

— APOLLO ENDOSURGERY INC 7.0%

Value ($000) $15,608 Shares 2,832,631 Est. Cost $5.33 Unrealized —

ADMA ADMA BIOLOGICS INC 5.5%

Value ($000) $12,150 Shares 5,000,000 Est. Cost $1.31 Unrealized +82.5%

URGN UROGEN PHARMA LTD 4.2%

Value ($000) $9,354 Shares 1,124,220 Est. Cost $7.11 Unrealized +16.4%

— AMARIN CORP PLC -ADR 4.2%

Value ($000) $9,317 Shares 8,547,965 Est. Cost $2.49 Unrealized —

LGND LIGAND PHARMACEUTICALS 3.9%

Value ($000) $8,573 Shares 99,562 Est. Cost $68.37 Unrealized -14.0%

RZLT REZOLUTE INC 3.7%

Value ($000) $8,147 Shares 2,973,205 Est. Cost $3.95 Unrealized -26.9%

— OPTINOSE INC 3.3%

Value ($000) $7,320 Shares 2,000,000 Est. Cost $1.62 Unrealized —

— AFFIMED NV 1.8%

Value ($000) $4,078 Shares 1,979,828 Est. Cost $2.77 Unrealized —

XGN EXAGEN INC 1.5%

Value ($000) $3,429 Shares 1,265,373 Est. Cost $11.52 Unrealized -51.6%

— CONFORMIS INC 1.5%

Value ($000) $3,309 Shares 17,304,350 Est. Cost $0.75 Unrealized —

OVID OVID THERAPEUTICS INC 1.3%

Value ($000) $2,835 Shares 1,540,671 Est. Cost $3.43 Unrealized -39.0%

ATYR ATYR PHARMA INC 0.8%

Value ($000) $1,803 Shares 600,980 Est. Cost $6.39 Unrealized -47.6%

— OPIANT PHARMACEUTICALS INC 0.7%

Value ($000) $1,637 Shares 152,278 Est. Cost $11.99 Unrealized —

EOLS EVOLUS INC 0.7%

Value ($000) $1,610 Shares 200,000 Est. Cost $10.60 Unrealized 0.0%

XOMA XOMA CORP 0.5%

Value ($000) $1,154 Shares 64,459 Est. Cost $20.39 Unrealized +1.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	AMRYT PHARMA PLC - SPNR ADR	6,227,733	$43,096	19.4%	$12.42	—	SPONSORED ADS	03217L106
QDEL	QUIDELORTHO CORP	501,633	$35,857	16.1%	$92.45	-3.2%	COM	219798105
—	CTI BIOPHARMA CORP	5,669,388	$32,996	14.8%	$3.66	—	COM	12648L601
XERS	XERIS BIOPHARMA HOLDINGS INC	12,928,168	$20,168	9.1%	$2.15	-22.9%	COM	98422E103
—	APOLLO ENDOSURGERY INC	2,832,631	$15,608	7.0%	$5.33	—	COM	03767D108
ADMA	ADMA BIOLOGICS INC	5,000,000	$12,150	5.5%	$1.31	+82.5%	COM	000899104
URGN	UROGEN PHARMA LTD	1,124,220	$9,354	4.2%	$7.11	+16.4%	COM	M96088105
—	AMARIN CORP PLC -ADR	8,547,965	$9,317	4.2%	$2.49	—	SPONS ADR NEW	023111206
LGND	LIGAND PHARMACEUTICALS	99,562	$8,573	3.9%	$68.37	-14.0%	COM NEW	53220K504
RZLT	REZOLUTE INC	2,973,205	$8,147	3.7%	$3.95	-26.9%	COM NEW	76200L309
—	OPTINOSE INC	2,000,000	$7,320	3.3%	$1.62	—	COM	68404V100
—	AFFIMED NV	1,979,828	$4,078	1.8%	$2.77	—	COM	N01045108
XGN	EXAGEN INC	1,265,373	$3,429	1.5%	$11.52	-51.6%	COM	30068X103
—	CONFORMIS INC	17,304,350	$3,309	1.5%	$0.75	—	COM	20717E101
OVID	OVID THERAPEUTICS INC	1,540,671	$2,835	1.3%	$3.43	-39.0%	COM	690469101
ATYR	ATYR PHARMA INC	600,980	$1,803	0.8%	$6.39	-47.6%	COM NEW	002120202
—	OPIANT PHARMACEUTICALS INC	152,278	$1,637	0.7%	$11.99	—	COM	683750103
EOLS	EVOLUS INC	200,000	$1,610	0.7%	$10.60	0.0%	COM	30052C107
XOMA	XOMA CORP	64,459	$1,154	0.5%	$20.39	+1.1%	COM NEW	98419J206